Ekaterina Sorokina

NanoVision Investments Group

NanoVision Group (NVI Group) is focused on creating a global multinational player in the ophthalmic marketplace able to provide the full range of advanced refractive technologies and support to help eye care professionals deliver optimal vision and lifestyle experiences to patients of all ages. Upon completion we will be able to deliver the full suite of advanced vision-correction technologies to practices around the world. We will offer the widest range of proven refractive technologies for myopia, hyperopia, astigmatism, presbyopia, cataract, spherical aberration and corneal health. Our portfolio of advanced technologies is designed to provide a vision improvement option for almost everyone and help them achieve greater freedom from compliance issues and better quality of life. We are dedicated to advancing the science of vision through continuous development of innovative technologies that enhance patient outcomes and improve practitioner productivity. To that end, we strive to constantly access the best ideas through an operating structure whereby Research & Development and Corporate Development are managed together under a single corporate function known as Strategy & Technology. This approach promotes a technological open-mindedness that ensures proper priorities of our internal R&D resources in concert with the pursuit of progressive innovations from outside the company.